Bacteria Drugs Genetic Engineering 
Scienmag
DECEMBER 9, 2020
A new genetic approach can accelerate the study of phage-microbe interactions with implications for health, agriculture, and climate Credit: Wikimedia Commons Scientists are continually searching for new and improved ways to deal with bacteria, be it to eliminate disease-causing strains or to modify potentially beneficial strains.
pharmaphorum
MAY 7, 2021
CRISPR’s deal with Nkarta aims to create genetically engineered NK cells, which are harvested and used to create a bank of “off the shelf” cells that can administered to patients like a drug. The post CRISPR Therapeutics begins natural killer cell cancer tie-up with Nkarta appeared first on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 4, 2021
Improper disposal of antibiotics also releases these drugs into the environment, and researchers working with these drugs in the lab also have concern over their ultimate effects on study results. ” The use of low-concentration fluoride costs only about four cents per liter.
The Pharma Data
OCTOBER 26, 2020
These mAbs are already of human origin and functionally optimized for high potency by the donor’s immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.
Roots Analysis
AUGUST 31, 2023
coli bacteria, as well as lambda bacteriophage, can adapt to the alterations in the composition of their nutrient medium. The same concept can be employed to discover novel drug targets and therapeutics for the treatment of various disorders.
Advarra
OCTOBER 10, 2024
Some have argued bacteria are developing antibiotic resistance faster than we can research, develop, test and approve new antibiotics. One possible solution to antibiotic resistance: bacteriophages (or phages), which are viruses that infect bacteria. Antibiotic resistance is an emerging problem.
Expert insights. Personalized for you.
52 
Let's personalize your content